MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
about
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic InterventionsCytokine-Defined B Cell Responses as Therapeutic Targets in Multiple SclerosisHypersensitivity Responses in the Central Nervous SystemB Cells and Autoantibodies in Multiple SclerosisB cells take the front seat: dysregulated B cell signals orchestrate loss of tolerance and autoantibody productionInebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical StudiesRestoring immune tolerance in neuromyelitis optica: Part IIEnvironmental factors in autoimmune diseases and their role in multiple sclerosisAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesGene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosisRelapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in miceInfluence of type I IFN signaling on anti-MOG antibody-mediated demyelination.Altered B cell signalling in autoimmunity.Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.Neuroantigen-specific autoregulatory CD8+ T cells inhibit autoimmune demyelination through modulation of dendritic cell function.Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis.MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration.Antibodies in multiple sclerosis oligoclonal bands target debrisCD4 T cell activation by B cells in human Leishmania (Viannia) infection.The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis.Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.Single dose of glycoengineered anti-CD19 antibody (MEDI551) disrupts experimental autoimmune encephalomyelitis by inhibiting pathogenic adaptive immune responses in the bone marrow and spinal cord while preserving peripheral regulatory mechanisms.Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targetsB-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity.Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.B lymphocytes in neuromyelitis opticaB cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosisChemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.IL-10 producing B cells partially restore E2-mediated protection against EAE in PD-L1 deficient mice.B Cell-Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus.Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentationThe Charcot Lecture | beating MS: a story of B cells, with twists and turns
P2860
Q26770664-E9FDD8CC-1AD1-4613-9078-06D4EC20C1DFQ26771459-73CC9845-7383-44B0-9D33-F1DC50C22359Q26779177-F4A7EB22-FBC2-4531-953A-894F369291A3Q26801386-647D17CB-B786-44CB-BB09-F3B95E1F1B0FQ26996644-75894936-C5E5-4F09-B78B-16EEB50C05BEQ28067334-29700232-2EBE-42E7-A821-CCFEDCA56A56Q28070136-2B55D028-6C71-4CC5-8C2B-F099BB4B975DQ28078461-46890DB0-61CA-43A5-BC4D-D03F86261B37Q28080791-23CE1252-F039-46B1-8C95-C22D0E98E970Q28540781-9D170465-CFBE-4C97-9150-FBF5D0D769AEQ30574747-B2E82FCA-8682-4207-BB7E-60A7D4E39EF4Q33645795-F094527B-64D4-4F1A-B3E7-8E92C1AFA987Q33751957-A06ACB75-8A3E-40C1-9761-DE74F06BFEB9Q33831179-4923A8C6-FCAC-48A7-AC4C-D6679652ECCDQ33924642-174F5BB1-07BE-4BE0-B6D5-6FAB0002BA1AQ34059107-8857A58A-43B3-4033-A694-2B3B9050A344Q34075707-7087E1AD-DE42-44D5-8F9A-F9B830706A58Q34332609-9ECA5514-21F7-4310-9FC7-559334F12F57Q34370104-18154997-4DB8-4851-BB12-425AC75FE29FQ34370120-6B417AC0-C282-460A-ACC4-9720208944F7Q34374669-F4AD6DD6-47D8-454B-9791-8D92842AB764Q34532315-5A91806F-57EB-4104-B248-A32640283D01Q35102709-19D7AED2-D40D-4E24-978F-311B9E13BC6EQ35105313-EFC73D82-3405-4519-A2A5-2B184999759CQ35179828-A1D98060-1C8B-41CA-9143-7AC88233D4E4Q35186239-87991577-B06C-49A7-917B-2065DC8242E0Q35216023-0BFA41DD-5D80-4061-91F2-884C8A9D04F0Q35463552-B1D55FC0-1EA3-4754-BF25-0A7FFD00D78BQ35514450-077D5B61-3662-4B7D-8ECF-8119887CF566Q35540927-DFCC7E19-8D4B-4DA1-BB4F-8619F70B62E8Q35591039-2CB3C856-2D3D-4273-9E3A-849FD0D1F2E6Q35613006-A8C0B6AF-85DC-4698-9D4A-136A173336B1Q35625089-B0C2D74C-B36A-4AA1-91FC-AB06F6211217Q35630131-3C9B3CCD-6E8D-4E3A-BA8D-3191D283CA4FQ35637528-9452B862-B771-48D0-8A1F-7120A4690606Q35674246-62EB9576-3546-461A-9270-27766147C976Q35880717-CE2BEBD2-D6FC-4317-85DE-26BCDAA6778BQ36031630-4864100B-A15B-47F2-8FBB-49D6F142841DQ36084774-E878E714-F1A8-4826-9BD6-2092565E6BCEQ36086475-6166A882-4C93-4FDE-A26B-325052B57B3F
P2860
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MHC class II-dependent B cell ...... of myelin-specific antibodies.
@en
MHC class II-dependent B cell ...... of myelin-specific antibodies.
@nl
type
label
MHC class II-dependent B cell ...... of myelin-specific antibodies.
@en
MHC class II-dependent B cell ...... of myelin-specific antibodies.
@nl
prefLabel
MHC class II-dependent B cell ...... of myelin-specific antibodies.
@en
MHC class II-dependent B cell ...... of myelin-specific antibodies.
@nl
P2093
P2860
P50
P356
P1476
MHC class II-dependent B cell ...... of myelin-specific antibodies.
@en
P2093
Anthony J Slavin
Aparna Shetty
Claude C A Bernard
Dieter E Jenne
Hartmut Wekerle
Juan C Patarroyo
Mark J Shlomchik
Martin S Weber
Michel Varrin-Doyer
Nicolas Molnarfi
P2860
P304
P356
10.1084/JEM.20130699
P407
P577
2013-12-09T00:00:00Z